Calyxo
Develops medical devices for kidney stone treatment and removal
$40MSeries F
Role not disclosedAB
Ally Bridge Group
Activity from announced rounds
Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $140M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionImperative Care
Develops treatments for patients suffering from thromboembolic disease
$100MGrowth
Role not disclosed